Thursday 23 March 2017

New Report Covers Global Anatomic Pathology Testing Market 2017-2021

Report Global Anatomic Pathology Testing Market 2017-2021 is a new market research publication announced by Reportstack. 
Report Outline: The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases.
For detailed report with TOC, please click here ​Global Anatomic Pathology Testing Market 2017-2021
Market Growth: The global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.
Key vendors • Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific
Other prominent vendors • 20/20 GeneSystems
• Abcam
• AdnaGen
• Advanced Cell Diagnostics
• Agendia
• Angsana Molecular & Diagnostics Laboratory
• AutoGenomics
• Biocare Medical
• Biocartis
• CellMax Life
• Cancer Genetics
• Digipath
• Enzo Biochem
• Epic Sciences
• Janssen Diagnostic
• Monogram Biosciences
• Nucleix
• Omnyx
• Oxford Cancer Biomarkers
• RareCyte
• SAKURA FINETEK USA
• Tecan
• VolitionRx
Regions Covered: 
• Americas
• APAC
• EMEA
Companies Mentioned
Abbott Diagnostics, Agilent Technologies, Danaher, Roche Diagnostics, Thermo Fisher Scientific, 20/20 GeneSystems, Abcam, AdnaGen, Advanced Cell Diagnostics, Agendia, Angsana Molecular & Diagnostics Laboratory, AutoGenomics, Biocare Medical, Biocartis, CellMax Life, Cancer Genetics, Digipath, Enzo Biochem, Epic Sciences, Janssen Diagnostic, Monogram Biosciences, Nucleix, Omnyx, Oxford Cancer Biomarkers, RareCyte, SAKURA FINETEK USA, Tecan, VolitionRx.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

No comments:

Post a Comment